Rafael Grochot, Medical Oncology Consultant, Principal Investigator at Sarah Cannon Research Institute, shared a post on LinkedIn:
“Had the pleasure of recently attending the AIS Congress 2026 in Montpellier, a renowned international forum dedicated to the development of therapeutic antibodies and new biotherapeutic modalities.
Honored to have shared the stage with Luis Álvarez-Vallina and Romain Remark during the Clinical Advancements of New Antibody Modalities session. I had the opportunity to discuss the latest achievements of ADCs for solid tumors in order to hopefully narrow the gap between benchside and clinic.
Thank you Ana Antunes for the invitation and impeccable organization.”
